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Abstract
Human hepatocytes are extensively needed in drug discovery and development. Stem cell-derived
hepatocytes are expected to be an improved and continuous model of human liver to study drug
candidates. Generation of endoderm-derived hepatocytes from human pluripotent stem cells (hPSCs),
including human embryonic stem cells and induced pluripotent stem cells, is a complex, challenging
process requiring specific signals from soluble factors and insoluble matrices at each developmental
stage. In this study, we used human liver progenitor HepaRG-derived acellular matrix (ACM) as a
hepatic progenitor-specific matrix to induce hepatic commitment of hPSC-derived definitive
endoderm (DE) cells. The DE cells showed much better attachment to the HepaRG ACM than other
matrices tested and then differentiated towards hepatic cells, which expressed hepatocyte-specific
makers. We demonstrate that Matrigel overlay induced hepatocyte phenotype and inhibited biliary
epithelial differentiation in two hPSC lines studied. In conclusion, our study demonstrates that the
HepaRG ACM, a hepatic progenitor-specific matrix, plays an important role in the hepatic
differentiation of hPSCs.
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1. Introduction
Human embryonic stem cells (hESCs) [1] and human induced pluripotent stem cells (hiPSCs) [2,3]
have the ability to form all cell types of an adult body; thus they are highly interesting sources of cells
for various human cell-based applications in the field of drug research. Hepatocytes are needed in
drug discovery and development for prediction of biotransformation pathways, possible drug-drug
interactions, and hepatotoxicity of a drug candidate. Differentiation of both hESCs and hiPSCs to
hepatocyte-like cells has been studied broadly [4-8]; but still the biggest challenge is to obtain mature
hepatocyte-like cells [9,10]. In the majority of the currently used differentiation protocols, stem cell
fate is guided towards hepatocyte-like cells solely by a stepwise growth factor treatment. It is,
however, known that not only soluble factors but also cell-cell interactions and cell-matrix
interactions play an important role in the complex, multistage hepatic cell differentiation process [11].
Biomaterials mimicking the extracellular matrix (ECM) are ideal for in vitro cell culturing since they
provide closely tissue-resembling microenvironments for cultured cells. ECM-mimicking in vitro
culture systems can be established by using natural biomaterials, such as decellularized matrix, also
called acellular matrix (ACM) [12] and ECM components, and synthetic biomaterials, such as
synthetic polymeric hydrogels. Decellularized whole organs are the most natural, simulating scaffolds
since tissue microarchitecture and its components such as proteins, glycosaminoglycans, and growth
factors can be well maintained [13]. These scaffolds are useful in whole organ engineering [14], but
due to demanding decellularization and repopulation processes using perfusion systems, they are not
optimal matrices for in vitro high-throughput drug testing during drug development. In addition,
whole organ ACM scaffolds cannot mimic a defined region of a tissue to induce cell type-specific
effects.
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During embryogenesis, the cells from definitive endoderm (DE) differentiate to a fully functional
adult hepatocyte fate under specific matrices and hormonal conditions [15]. To mimic the in vivo
differentiation process, in vitro hepatic  differentiation  most  commonly  starts  from  DE  cells.  The
soluble factors used during in vitro hepatic differentiation have been given most of the focus of
research efforts because they are available commercially in purified forms and can be easily added
into culture media. Contrary, the optimal matrix for in vitro hepatic commitment of the DE cells is
poorly understood, partially due to the complexity of matrix and unavailability of specific matrix
components. Here we show that human liver progenitor cell-derived ACM supports the attachment
of DE cells and their hepatic differentiation.
2. Materials and methods
2.1. Preparation of the ACM
We prepared the ACM from human liver progenitor HepaRG cells. The HepaRG cells [16] were
obtained from Biopredic (Saint-Grégoire, France), and they were plated at 26,000 cells/cm2 density
and cultured for two weeks in previously prescribed culture conditions during which the cells are
known to differentiate to hepatocyte-like cells and cholangiocyte-like cells through a bipotent
progenitor [17,18]. Decellularization was performed as described earlier [19] with some
modifications. The cell monolayer was first washed once with distilled water (Gibco, 15230-089) and
then incubated with water for 45 minutes at 37°C. Next, the ACM was washed twice with water to
ensure complete removal of the cells, and was used immediately for DE cell differentiation. The
complete  removal  of  HepaRG  cells  from  the  ACM  using  this  protocol  was  confirmed  by  DAPI
staining and Filamentous actin staining with Alexa Fluor 594 phalloidin (Invitrogen, A12381, 1:50)
(data not shown).
2.2. Cell cultures
The hESC lines WA07 and H9 [1] and hiPSC line iPS(IMR90)-4 [3] were purchased from WiCell
research institute. H9 cells were genetically modified to H9-GFP cells as described earlier by us [20].
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Stem cells were maintained in standard Matrigel culture system (BD Biosciences, 356230, 0.5 mg
per one 6-well plate) in mTeSR™1 medium (STEMCELL™ Technologies, 05850). The medium was
changed daily. The WA07 and iPS(IMR90)-4 cells were passaged at a ratio of 1:5 every four days by
using Versene 1:5000 (Invitrogen, 15040033). The H9-GFP cells were passaged at a ratio of 1:4-1:6
every four days by using Dispase (STEMCELL™ Technologies, 07923). Prior to cell passaging,
differentiated cell areas were removed manually. All the cell cultures were maintained at 37°C in a
humid atmosphere with 5% CO2. The WA07, H9-GFP, and iPS(IMR90)-4 cells used in this study
were at passages p38, p18(13)-p22(17), and p18+39(14), respectively.
HepaRG  cells  used  as  controls  in  qPCR  were  cultured  for  two  or  four  weeks  in  the  conditions
described above. In the four-week culture, the medium was supplemented with 2% DMSO during the
last two weeks to induce the maturation to hepatocyte-like cells.
2.3. Differentiation of the human pluripotent stem cells (hPSCs) to DE cells
Different induction medium compositions were tested to maximize the differentiation efficiency of
the hPSCs to DE cells. RPMI-1640 medium (Gibco, 31870-025) was supplemented with four
different  sets  of  supplements  (Fig.  1A).  The  selection  of  the  supplements  was  based  on  earlier
publications [21,22]. The media M1, M2, M3, and M4 were tested with the iPS(IMR90)-4 cells,
media M2 and M4 with the WA07 cells, and medium M1 with the H9-GFP cells. The DE induction
was performed for six days, and the media were renewed daily. The best medium was selected for
each cell line for generating DE cells for the subsequent differentiation steps.
2.4. Hepatic differentiation of the DE cells
The DE cells were detached by a Cell Dissociation Buffer (Gibco, 13151-014) for 15 minutes at 37˚C
followed by an Accutase cell detachment solution (Millipore, SCR005) for one to two minutes at
room temperature. The hPSC-derived DE cells were seeded at a ratio of 1:1 onto the HepaRG-ACM.
For comparison, we plated the DE cells on a standard cell culture dish, Matrigel-coated dish, rat
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collagen type I-coated dish, mouse laminin-111-coated dish, or human collagen type III-coated dish.
Matrigel coating was prepared according to the protocol used in the hPSC culture. A 12-well tissue
culture plate was coated with collagen type I (Cultrex, 3440-100-01) at 50 µg/ml, laminin-111
(Cultrex, 3400-010-01) at 25 µg/ml, or collagen type III (Sigma, C4407) at 25 µg/ml for two hours
at room temperature. Hepatic differentiation of the DE cells was induced in three steps. First, the cells
were cultured in Hepatocyte Culture Medium (HCM™ SingleQuots™ Kit; Lonza CC-4182, without
rhEGF and gentamicin-amphotericin-1000) supplemented with 5 ng/ml fibroblast growth factor 4
(FGF4, PeproTech, 100-31), 10 ng/ml bone morphogenetic protein 2 (BMP2, PeproTech, 120-02),
and 10 ng/ml BMP4 (PeproTech, 120-05) for four days. Next, the cells were incubated in HCM
supplemented with 10 ng/ml hepatocyte growth factor (HGF, PeproTech, 100-39), 10 ng/ml
Oncostatin M (OSM, PeproTech , 300-10T), and 0.1 µM  Dexamethasone (DEX, Sigma-Aldrich,
D4902) for two to three days  (WA07 and iPS(IMR90)-4) or four to six days (H9-GFP). Finally, the
cells were cultured in HCM supplemented with 0.1 µM DEX for five days. Matrigel overlay was used
in the last step of the differentiation. Briefly, the ice-cold Matrigel (BD Biosciences, 356230) was
diluted into the medium at a concentration of 0.233 mg/ml and then added on top of the cells. After
overnight incubation at 37°C, the Matrigel solution was gently replaced by the fresh medium.
2.5. Flow cytometry
The cells were detached by a Cell Dissociation Buffer and Accutase as described above. Single cell
suspension was first incubated with mouse anti-stage-specific embryonic antigen-4 (SSEA-4,
Developmental Studies Hybridoma Bank, MC-813-70, 1:400 in 2% FBS), rat anti-SSEA-3 IgM
(STEMCELL™ Technologies, 01553, 1:100 in 2% FBS), or mouse anti-chemokine receptor type 4
(CXCR-4, R&D Systems, MAB172, 1:50 in 2% FBS) on ice for 60 min. After washing, the cells were
incubated with APC-conjugated goat anti-mouse IgG (H+L) (SouthernBiotech, 1031-11S, 1:300 in
2% FBS), APC-conjugated goat anti-rat IgM (STEMCELL™ Technologies, 10215, 1:100 in 2%
FBS), or APC-conjugated goat anti-mouse IgG (H+L) (Beckman Coulter, 736830, 1:50 in 2% FBS)
7
on ice for 40 min in dark. The negative control sample was stained only with the secondary antibody.
Cells were analyzed on a BD LSR II flow cytometer (633 nm laser, 660/20 BP filter detector) using
BD FACSDiva software. The overlay histograms were created with Flowlogic software.
2.6. Immunostaining
For immunofluorescence cells were cultured in 8-well Lab-Tek® Chamber Slide™ systems (Nunc,
177445) or black 96-well µ-plates (ibidi, 89626). Cells were fixed with 4% paraformaldehyde for 10
minutes, permeabilized with 0.1% Triton X-100 or 0.5% Saponin for 10 minutes, and blocked with
10% normal goat or donkey serum (Millipore) for one hour. Cells were incubated with the primary
antibodies (Table S1) overnight at +4°C. Negative controls were rabbit IgG (Santa Cruz
Biotechnology, sc-2027), mouse IgG (Santa Cruz Biotechnology, sc-2025), and goat IgG (Santa Cruz
Biotechnology, sc-2018). Next day the cells were incubated with the secondary antibody conjugated
with Alexa Fluor 594 (Invitrogen, 1:400) for one hour. Filamentous actin was stained with Alexa
Fluor 594 phalloidin (Invitrogen, A12381, 1:50). Nuclei were stained either with DAPI (Sigma-
Aldrich, D8417, 25 µg/ml in MilliQ water) or with 0.2 µM SYTOX green (Invitrogen, S7020). The
protein expression was visualized with a Leica TCS SP5II HCS A confocal microscope with an HCX
PL APO 20x/0.7 Imm Cor (glycerol) objective. DAPI was excited with UV (diode 405 nm/50 mW),
SYTOX green with an Argon 488 nm laser, and Alexa Fluor 594 with a DPSS (561 nm/20 mW) laser.
The images were analyzed with Imaris 7.4 program (Bitplane) by creating slices or easy three-
dimensional (3D) images. Immunofluorescence of the H9-GFP cells and their derivatives was imaged
with a Zeiss Axioplan microscope.
2.7. RNA isolation, real-time qPCR, and analysis of the real-time qPCR data
Total RNA was extracted from the H9-GFP cells and their derivatives using a TRIzol reagent
(Invitrogen, 15596) following the manufacturer’s instructions. Other cells were lysed with a RLT-
buffer (Qiagen), and total RNA was extracted using an RNeasy Mini kit (Qiagen, 74104) according
to the manufacturer’s instructions. Primary human hepatocytes (BD Biosciences, 454503, lot 95 and
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lot 99) were used as controls. The frozen primary human hepatocytes were recovered by using a
cryopreserved hepatocyte purification kit (BD Biosciences, 454500) according to the manufacturer’s
instructions. RNA concentrations were measured with a NanoDrop 2000 spectrophotometer (Thermo
Fischer Scientific). The RNA was converted to cDNA with a High Capacity RNA-to-cDNA kit
(Applied Biosystems, 4387406). The cDNA samples (10 ng in 20 µl reaction) were analyzed in
duplicate on a StepOnePlus Real-Time PCR System (Applied Biosystems) using a Fast SYBR Green
Master Mix (Applied Biosystems, 4385612). Housekeeping gene ribosomal protein, large, P0
(RPLP0) served as an endogenous control. PCR cycles were as follows: 40 cycles at 95°C for 3 s and
annealing/extension at 60°C for 30 s. The primers were designed by Primer Express v2.0 software
(Applied Biosystems) except the primers for OCT4 [3]  and HNF3B [21].  All  the  primers  were
synthesized by Oligomer Oy (Helsinki, Finland), and their sequences are shown in Table S2. A
standard curve for each gene was generated, and the amplification efficiency was used in calculating
the relative quantification of the target gene in comparison to the housekeeping gene with an earlier
described mathematical model [23].
2.8. ALB secretion and total protein analysis
The hepatic functions of the derived cells were analyzed by determining the secreted ALB. Cell
culture media were collected 24 h after medium renewal and frozen for later analysis. Each collected
medium sample was analyzed in duplicate with a Human Albumin ELISA kit (Bethyl Laboratories)
following the manufacturer’s instructions. The secreted ALB amount was calculated with a standard
curve and normalized with the total cellular protein amount. The cellular protein samples were
prepared as follows: cells were lysed with a RIPA buffer (Pierce Biotechnology), and the total protein
amount was quantified with a BCA Protein Assay kit (Pierce Biotechnology) according to the
manufacturer’s instructions.
3. Results
3.1. Characterization of the hPSCs
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Before differentiating the hPSCs towards DE cells, we checked their pluripotency.
Immunofluorescence of the key pluripotent markers showed that the WA07 and iPS(IMR90)-4 cells
highly expressed the transcription factor OCT4 and the surface marker SSEA-4 and that the H9-GFP
cells highly expressed OCT4 (Fig. S1A). In addition, flow cytometry showed that 99.7% of the WA07
cells and 93.5% of the iPS(IMR90)-4 cells were positive for SSEA-4 and that 95.3% of the H9-GFP
cells were positive for SSEA-3 (Fig. S1B). The H9-GFP, WA07, and iPS(IMR90)-4 cells did not
express the hepatic differentiation markers AFP and HNF4A (Fig. S2A).
3.2. Differentiation of the hPSCs to DE cells
We first  differentiated  the  H9-GFP cells  to  DE cells  in  the  medium M1 (Fig.  1A)  according  to  a
published protocol [24]. After six days in the medium M1, the cells showed uniform morphology
(Fig. 1E). The majority of the derived cells were positive for the DE markers HNF3B and CXCR-4
(Fig. 2), and 95.7% of them expressed CXCR-4 (Fig. 1F). When using the same medium M1 for the
WA07 and iPS(IMR90)-4 cells, a pure cell population with DE morphology was produced already in
the first one to two days followed by a massive cell death (Fig. 1B). The derived DE cells continued
dying in the medium M1, and therefore the yield was very low. To optimize the induction medium
used to differentiate the WA07 and iPS(IMR90)-4 cells to DE cells, we tested four different media
(Fig. 1A). The media containing Activin A and B-27 (M2 and M4) yielded much more DE cells
compared with the media containing also Wnt-3a and sodium butyrate (M1 and M3). Indeed, after
two days of the induction, the iPS(IMR90)-4-derived DE cells in the Wnt-3a and sodium butyrate
supplemented media were severely suffering (Fig. 1B). Due to the low yield of DE cells, we did not
continue these cultures any longer. We also tested two Activin A products. We did not notice
remarkable difference in the phenotype of the WA07 or iPS(IMR90)-4-derived DE cells between two
Activin A products as the cell morphology, cell density, and CXCR-4 expression in the hPSC-derived
DE cells were similar (Fig. 1C, 1D and 1F). The medium M2 was chosen for generating DE cells
from the WA07 and iPS(IMR90)-4 cells for the following differentiation to hepatic lineage.
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After six days of DE induction, the majority of the WA07 and iPS(IMR90)-4-derived cells expressed
HNF3B and CXCR-4 proteins (Fig. 2), but not AFP or HNF4A proteins (Fig. S2B). Flow cytometry
revealed that 93.8% of the WA07-derived DE cells and 82% of the iPS(IMR90)-4-derived DE cells
were positive for CXCR-4 (Fig. 1F).
3.3. Hepatic differentiation of the hPSC-derived DE cells
The DE cells were differentiated towards hepatic cells with a three-step differentiation protocol,
namely hepatic commitment, hepatic progenitor expansion, and hepatic maturation (Fig. 3A). The
DE cells were produced in a Matrigel-coated dish where the hPSCs were cultured. As Matrigel may
not be an ideal matrix for hepatic commitment of the DE cells, we tested different matrices for the
attachment of the hPSC-derived DE cells. Only a few DE cells attached to the standard cell culture
dish, Matrigel-coated dish, rat collagen type I-coated dish, and mouse laminin-111-coated dish (Fig.
S3), and none attached to human collagen type III-coated dish (data not shown). Therefore, these
cultures were stopped after two days. In contrast, the DE cells well attached to the HepaRG-derived
ACM (Fig. S3). We then induced hepatic commitment in this condition using BMP2, BMP4, and
FGF4. The H9-GFP, WA07, and iPS(IRM90)-4-derived DE cells formed confluent monolayer on the
HepaRG-ACM after four-day treatment (Day 10, Fig. 3B). The cells showed polygonal-shaped
morphology with cytoplasmic vacuoles and pericytoplasmic actin as seen under a phase contrast
microscopy and by F-actin staining, respectively (Fig. 3B and 3C). Some of the cells were
binucleated. These morphological characteristics were previously reported for hESC-derived
hepatocytes [6,25] and were similar to cultured human primary hepatocytes [26-28]. The H9-GFP-
derived cells formed homogenous monolayer by day 18 (Fig. 3B). The expression of hepatic
progenitor markers was studied by immunofluorescence. The WA07, iPS(IMR90)-4, and H9-GFP-
derived progenitors expressed HNF4A and CK-19 proteins (Fig. 4A), but they were negative for AFP
on day 10 (data not shown). The protein expression level seems to vary among the cells in the same
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culture, particularly in the H9-GFP cells. The WA07-derived cells showed the highest expression
level of HNF4A protein among the three cell lines. The AFP protein expression appeared later, on
day 13 in the WA07 and iPS(IMR90)-4-derived progenitors and on day 14 in the H9-GFP-derived
progenitors (Fig. 4B).
In the next differentiation steps, the hepatic progenitors were expanded in the presence of HGF, OSM,
and DEX, after which hepatic maturation was induced by DEX. Matrigel overlay was tested during
the maturation. The expression of hepatic markers was studied at protein level. On day 18, the WA07-
derived hepatic cells were highly positive for HNF4A and partially positive for ALB, CYP3A4, and
AFP shown by immunofluorescence (Fig. 5). The iPS(IMR90)-4-derived cells were weakly positive
for HNF4A and CYP3A4, and negative for ALB. The minority of the iPS(IMR90)-4-derived cells were
positive for AFP. The majority of the H9-GFP-derived hepatic cells were positive for HNF4A and
partially positive for ALB and AFP (Fig. 5). In our preliminary tests, we observed cell migration and
formation of ductular structures that eventually detached from the culture dish in the presence of HGF
in the hepatic maturation step (Fig. S4). When HGF was omitted and Matrigel overlay was applied,
the formation of ductular structures was prevented. Matrigel overlay showed little effect on the
protein expression of the studied markers in the WA07 and iPS(IMR90)-4 cells, but it decreased the
AFP protein expression and induced the expression of a hepatic transporter protein, MRP2, in the H9-
GFP-derived hepatic cells on day 19 (Fig. 5). Without Matrigel overlay, the MRP2 protein was not
detected in the H9-GFP-derived hepatic cells on days 14, 16, and 21 (data not shown).
Hepatic functions of the H9-GFP-derived cells were investigated by measuring ALB secretion. From
day 16 to day 21, the hepatic cells increased their ALB protein production, and on the last time point,
the cells secreted 119 ng ALB per mg total cellular proteins per day (Fig. S5).
3.4. Gene expression profiles in the hPSCs and their derivatives during differentiation
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We studied the transcriptional profiles of pluripotency and liver specific genes in the three cell lines
during the differentiation and also compared the levels with those in the human primary hepatocytes,
HepaRG, and HepG2 cells by qPCR. The mRNA expression levels of the pluripotency markers OCT4
(Fig. 6) and NANOG (Fig. S6) in the WA07 and iPS(IMR90)-4-derived cells decreased to the levels
similar to those in the human primary hepatocytes and HepaRG cells as shown by qPCR. The mRNA
expression of HNF3B (FOXA2), a maker of foregut endoderm [29], increased about 200-250-fold in
the DE cells (day 6) and hepatic progenitor cells (day 10) and then dropped to the level similar to that
in the HepaRG cells, which was much lower than that in the human primary hepatocytes (Fig. 6). The
mRNA expression of the liver specific cytokeratins CK-8 and CK-18 increased to the maximal levels
at day 12 and then decreased at day 17 in the WA07 and iPS(IMR90)-4-derived cells (Fig. 6). In the
H9-GFP  cells,  the  mRNA  expression  of CK-8 and CK-18 was constantly increasing during
differentiation (Fig. S7). The WA07, iPS(IMR90)-4, and H9-GFP-derived cells still expressed AFP
and CK-19 in the final studied time point, which indicates that the cells were not mature hepatocytes
yet (Fig. 6 and S7). The expression of the hepatocyte markers ALB and alpha-1 antitrypsin (AAT) was
increasing during the culture period confirming the hepatic lineage differentiation, but the expression
level was much lower than the levels in the human primary hepatocytes, HepaRG cells, or HepG2
cells (Fig. 6 and S7).
Matrigel overlay greatly increased the mRNA expression of ALB and AAT and slightly decreased the
mRNA expression of CK-19 in the WA07-derived hepatic cells compared with the cells without
Matrigel overlay, but it did not affect the expression of AFP (Fig. 6A). On the other hand, the
expression of APF, ALB, and AAT in the iPS(IMR90)-4-derived cells was decreased in the presence
of Matrigel overlay (Fig. 6B).
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We were interested to know how the markers of hepatic stem cells and hepatoblasts changed during
the differentiation. Neural cell adhesion molecule 1 (NCAM1), a marker of hepatic stem cells [30],
was expressed at a very low level in the human primary hepatocytes but at much higher levels in the
WA07 and iPS(IMR90)-4-derived hepatic cells and HepaRG cells (Fig. S6). Intercellular adhesion
molecule 1 (ICAM1), a marker of hepatoblasts [30], was expressed at lower levels in the WA07 and
iPS(IMR90)-4-derived hepatic cells than in the human primary hepatocytes and HepaRG cells (Fig.
S6).
The mRNA expression of ATP-binding cassette, sub-family B, member 1 (MDR1, ABCB1), one of
the important drug transporters, in the H9-GFP cells was increased during the differentiation (Fig.
S7), but the level was still lower than those in the HepaRG and HepG2 cells.
We also noticed that HepaRG cells expressed a hepatoblast marker, CK-19,  which  was  slightly
increased by the 2-week treatment with 2% DMSO (Fig. 6). The mRNA expression levels of CK-8
and CK-18 in the 2-week cultured HepaRG cells was similar to that in the undifferentiated stem cells,
but was increased by the 2-week treatment with 2% DMSO (Fig. 6). This confirms that the HepaRG
cells used to produce the ACM were at the progenitor stage.
4. Discussion
Human  PSCs  offer  a  great  supply  of  all  types  of  somatic  cells  for  basic  research  and  biomedical
applications, and thus the in vitro differentiation has been extensively studied. Generation of DE-
derived hepatocytes from hPSCs is a complex, challenging process requiring specific signals from
soluble factors and insoluble matrices at each developmental stage. In the present study, we exploited
the use of HepaRG-derived ACM in hepatic differentiation of hPSCs and found that the HepaRG-
ACM supported the attachment of hPSC-derived DE cells and their differentiation towards hepatic
cells.
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4.1. The role of the ECM in hepatic commitment of DE cells
The ECM is dynamic, and its remodeling is an important mechanism by which cell differentiation
and tissue formation are regulated [31,32]. To induce hepatic commitment, most attention and effort
have been paid to the selection of soluble factors, but not to the compositions of matrices. Little is
known about the exact matrix environments for DE induction and hepatic commitment. Researchers
have used the same matrices for both DE induction of hPSCs and hepatic commitment of DE cells,
such as feeder cells [4,6] or Matrigel [7], which are used for the culture of hPSCs. We hypothesized
that the ACM derived from the human liver progenitor HepaRG cells would provide the environment
for the hepatic commitment of hPSC-derived DE cells. The HepaRG-derived ACM represents a
hepatic progenitor-specific matrix for DE cells because the next step in the hepatic differentiation
process for DE cells is hepatic progenitor. We observed good attachment of the DE cells on the
HepaRG-ACM. In contrast, we saw a poor or lack of the DE cell attachment to the standard cell
culture dish, Matrigel-coated dish, collagen type I-coated dish, laminin 111-coated dish, and collagen
III-coated dish. The hESC-derived DE cells have earlier been reported to attach to collagen type I
[5,6]. To select the optimal matrix components for hESCs and DE cells, researchers have focused on
the expression of integrins. An earlier study revealed that a set of six integrins were upregulated in
hESC-derived DE cells and that fibronectin and vitronection promoted efficient pancreatic
differentiation of DE cells [33]. Another study described the finding of integrins αV and β5 on DE
cells and suggested that vitronectin would be a suitable matrix [34]. Many integrins can bind to more
than one ligand. For example, integrins αV and β5 can bind not only to vitronectin, but also to bone
sialoprotein and osteopontin [35]. Cells may express more than one pair of integrins, as described
earlier [33]. Thus, studying the expression of integrins makes it less efficient to screen for the optimal
matrices. In contrast, our approach was to provide the liver progenitor environment to DE cells in
order to induce hepatic commitment. Plating DE cells to a suitable environment also purifies the cell
population and removes unwanted cell types. The characterization of the HepaRG-ACM is under
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investigation in our laboratory, and it will guide us to produce fully synthetic matrix without human-
derived components.
Acellular matrices are attractive in vitro culture scaffolds offering close mimics of in vivo cellular
microenvironment since the physical structure together with biochemical components can be well-
preserved after decellularization process [36]. Whole livers [36], liver slices [37], and cultured liver
cells [19] have been used to produce ACM. Decellularized whole organs are suitable in the near future
for organ transplantation [38]; however, the complex decellularization process of whole organs and
the variability between organs hinder their use in industrial scales, particularly in drug testing
applications. On the other hand, the decellularization of cultured cells can be performed without
sophisticated equipment. In addition, cell-derived ACM can exert cell type-specific effect. Cultured
cell-derived ACM has been used in directing the differentiation of ESCs to pancreatic cells [39] and
the osteogenesis [40], adipogenesis [41], and chondrogenesis [42] of mesenchymal stem cells
(MSCs). The fetal MSC-derived ACM was shown to enhance the ex vivo expansion of adult MSCs
[43].
4.2. DE differentiation conditions vary between hPSC lines
DE-like cells have been generated from hPSCs in feeder-free culture without serum using various
combinations of the following components: Activin A [21], B-27 [22], Wnt-3a and sodium butyrate
[7,24], insulin-transferrin-selenium, and albumin [4]. We used different DE induction media for the
H9-GFP cells than for the WA07 and iPS(IMR90)-4 cells since we noticed that the media
supplemented with Wnt-3a and sodium butyrate reduced cell viability. Thus, the optimization of DE
induction step is crucial, and in our experience it is needed for every hPSC line. Although different
DE induction media were used, the expression of the DE markers CXCR-4 and HNF3B was increased
to a similar extent in all the studied cell lines after six days of induction. We obtained about 82-96%
CXCR-4 positive cells and more than 90% HNF3B positive cells from all three cell lines at this stage.
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The reason for such difference in DE induction conditions between cell lines is unknown and is
currently under investigation in our laboratory. Sodium butyrate is a known inhibitor of histone
deacetylase [44], and at the concentration of 0.5 mM and above, it can cause cell differentiation
followed by cell death [45]. Considerable cell death in the DE induction of hESCs was reported earlier
[46].
4.3. Differentiation capacity varies between hPSC lines
In this study, we have found that different hPSC lines responded differently to the hepatic
differentiation conditions. Before hepatic differentiation, the DE cells derived from all three cell lines
expressed CXCR-4 and HNF3B at similar levels. Immunofluorescence showed that more than 90%
of the DE cells were positive for HNF3B, indicating that the cells from all three cell lines should be
competent to commit to hepatic lineage because HNF3B plays a critical role in the initiation of early
liver development [29] but is not important in maintenance of liver functions in adult hepatocytes
[47]. Immunostaining of the lineage markers suggests that the WA07 cells have the best hepatic
differentiation capacity among all three cell lines tested. More than 90% of the WA07 cells on day
10 and H9-GFP cells on day 16 were positive for HNF4A; however, this was not the case for the
iPS(IMR90)-4 cells. The study on mouse embryonic development demonstrated the critical role of
HNF4A in functional liver development [48]. The low expression level of HNF4A in the iPS(IMR90)-
4-derived cells may explain the failure of the hepatic differentiation.
The variability of hepatic differentiation between hPSC lines has been noted before. An earlier study
compared 28 hiPSC lines and found that hiPSCs derived from adult fibroblasts differentiated poorly,
which was attributable to donor differences [49]. Variations have also been observed in neural
differentiation [50] and endothelial differentiation [51] of different hPSC lines.
4.4. Maturation of hPSC-derived hepatic cells remains a challenge
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Adult, mature hepatocytes have not so far been generated from hPSCs [9,10]. The phenotype of
hPSC-derived hepatic cells closely resembles a fetal, immature hepatocyte phenotype [9,10]. All the
hepatocyte-like cells derived from hPSCs reported earlier were AFP positive [4,6,7,22,24,49].
Ogawa, et al. successfully decreased the number of AFP positive  cells  to  34%  by  using  cyclic
adenosine monophosphate in aggregate culture [52]. In this study, we attempted to improve hepatic
maturation by using several methods. HGF can induce the proliferation of hepatocytes but also their
transdifferentiation to biliary epithelia [53,54]. Therefore, we used HGF during the hepatic expansion
step and then removed it from the hepatic maturation step. Additionally, we applied Matrigel overlay
in the hepatic maturation step because Matrigel overlay was earlier shown to inhibit biliary epithelial
differentiation of primary mature adult hepatocytes and induce a mature hepatocyte phenotype [53].
In our preliminary tests, we observed cell migration and eventually the formation of ductular
structures similar to bile ductules in the presence of HGF in the hepatic maturation step. This
phenomenon has also been observed in primary hepatocyte culture [53]. When we omitted HGF and
applied Matrigel overlay in the hepatic maturation step, we were able to prevent the formation of the
ductular structures. In addition, we found that Matrigel overlay enhanced hepatocyte phenotype,
evidenced by the increased expression of ALB and AAT in the WA07 cells, decreased expression of
CK19 in the WA07 cells, increased expression of MRP2 in the H9-GFP cells, and decreased
expression of AFP in  the  H9-GFP  cells.  The  reason  why  Matrigel  overlay  did  not  produce  the
expected effect on the iPS(IMR90)-4-derived cells might be that the cells under Matrigel overlay
were phenotypically different from those derived from the WA07 and H9-GFP cells, as seen from
the immunofluorescence of the lineage markers. Since the derived cells from all three hPSC lines
were still positive for the immature marker AFP except the H9-GFP-derived cells under Matrigel
overlay, we did not measure mature liver functions related to drug metabolism and transport.
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To promote hepatic maturation, the optimal matrices should be used together with soluble factors,
which can maintain hepatocyte phenotype and inhibit biliary epithelial differentiation. The
knowledge obtained from primary hepatocyte cultures can be utilized in the hepatic maturation step
of hPSC differentiation. Various culture systems have been developed to maintain and enhance liver
functions of primary hepatocytes. Sandwich culture [55], 3D scaffolds [56], and microcapsules
[57,58] have been used successfully to enhance liver functions of primary hepatocytes. In addition,
in view of our findings mentioned above and also in view of other findings about the role of ACM in
directing stem cell fate, reviewed by Hoshiba, et al [13], a complete in vitro hepatic maturation may
require a specific matrix environment.
5. Conclusions
The ECM and ECM-mimicking biomaterials have recently been shown to be important in controlling
stem cell fate. The ECM is dynamic, and its remodeling is an important mechanism by which cell
differentiation and tissue formation are regulated. For in vitro stem cell differentiation, the dynamic
feature of the ECM must be understood to produce desired cell phenotypes. This study shows that the
human liver progenitor HepaRG-derived ACM promotes the hepatic commitment and further
differentiation of the hPSC-derived DE cells. Our study sheds light on the important role of the ECM
in directing stem cell fate and provides new approaches to the improvement of hepatic maturation.
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Figure Legends
Fig.  1.  Optimization  of  the  medium  components  for  the  DE  induction.  (A)  The  reagents  used  to
supplement RPMI-1640 medium for the DE induction media M1, M2, M3, and M4. (B) The
iPS(IMR90)-4 cells in the DE induction media on day 2. (C) The iPS(IMR90)-4 cells after 6 days in
the M2 and M4 media. (D) The WA07 cells after 6 days in the M2 and M4 media. (E) The H9-GFP
cells after 6 days in the M1 medium. Scale bars = 100 µm. (F) Flow cytometry analysis of the CXCR-
4 expression in the WA07 and iPS(IMR90)-4-derived cells after 6 days in the media M2 and M4 and
H9-GFP-derived cells after 6 days in the medium M1.
Fig. 2. Characterization of the hPSC-derived DE cells. Immunofluorescence of HNF3B and CXCR-
4. Scale bars = 100 µm. 20x magnification for the H9-GFP cells.
Fig. 3. Hepatic differentiation of the hPSC-derived DE cells in the HepaRG-derived ACM system.
(A) A stepwise differentiation process. (B) Phase contrast microscope images of the cells at different
time points. (C) Filamentous actin (F-actin) staining shows polygonal-shaped morphology of the
iPS(IMR90)-4-derived cells. F-actin = red, nuclei = blue. MO = Matrigel overlay. Scale bars = 100
µm.
Fig. 4. Immunostaining of the liver markers in the cells differentiated on the HepaRG-derived ACM.
(A) The cells on day 10. (B) The WA07 and iPS(IMR90)-4 cells on day 13 and H9-GFP cells on day
14. Scale bars = 100 µm. 10x magnification for the H9-GFP cells.
Fig. 5. Effect of Matrigel overlay (MO) on hepatic maturation. Immunostaining of the liver markers
in the WA07 and iPS(IMR90)-4 cells on day 18 and in the H9-GFP cells on day 16 and day 19 (+
MO). Scale bars = 100 µm. 10x magnification for the H9-GFP cells.
Fig.  6.  Relative mRNA expression of the pluripotency and liver markers in the WA07 and
iPS(IMR90)-4 cells during the differentiation. The mRNA expression of OCT4, HNF3B, AFP, CK-
19, CK-18, CK-8, ALB, and AAT in the WA07 (A) and iPS(IMR90)-4 (B) cells during the
differentiation was analyzed by real-time qPCR. Relative mRNA expression was normalized to the
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control gene RPLP0, and fold inductions were calculated with reference to the undifferentiated WA07
or iPS(IMR90)-4 cells on day 0. N = 3 biological samples. Error bars are SD. MO = Matrigel overlay;
PHH 1: primary human hepatocytes (BD Biosciences, 454503, lot 95); PHH 2: primary human
hepatocytes (BD Biosciences, 454503, lot 99); HepaRG 1: two-week culture without DMSO
treatment; HepaRG 2: two-week culture without DMSO treatment followed by two week
differentiation in 2% DMSO.
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Fig. S3. DE cell attachment on different 
coatings one day (iPS(IMR90)-4 and H9-GFP)







Antibodies used in immunofluorescence.




Alpha fetoprotein (AFP) Sigma-Aldrich A8452 1:500
Albumin (ALB) Bethyl Laboratories A80-229A 1:500





CXCR-4 R&D Systems MAB172 1:50
Cytochrome P450 3A4 (CYP3A4) Millipore AB1254 1:500
Hepatocyte nuclear factor 3B (HNF3B,







ATP-binding cassette, sub-family C,
member 2 (MRP2, also known as
ABCC2)
abcam ab3373 1:50









Primers used in real-time qPCR.
Gene Accession Size
(bp)


















AFP NM_001134.1 79 F: GTTGCCAACTCAGTGAGGACAA
R: CTGATACATAAGTGTCCGATAATAATGTCA






CK-19 NM_002276.4 142 F: AGCATGAAAGCTGCCTTGGA
R: CCTGATTCTGCCGCTCACTATC
ALB NM_000477.3 85 F: AAGTGGGCAGCAAATGTTGTAA
R: AACTGGTTCAGGACCACGGATA
AAT NM_000295.3 135 F: GGCCAAGAAACAGATCAACGAT
R: GGTCTCTCCCATTTGCCTTTAA
ICAM1 NM_000201.2 107 F: TGAGCAATGTGCAAGAAGATAGC
R: CACCCGTTCTGGAGTCCAGTAC
NCAM1 NM_000615.5 144 F: GGTGCCCATCCTCAAATACAAA
R: CTTACGGCGTACGTTGTTTCG
MDR1 NM_000927.4 202 F: GCTCCTGACTATGCCAAAGC
R: TCTTCACCTCCAGGCTCAGT
Extracellular matrix  
secreted by HepaRG cells
Decellularization hPSC-derived  
definitive endoderm cells







∑ We first report HepaRG acellular matrix (ACM) promotes hepatic commitment of hPSCs.
∑ Definitive endoderm cells attached and differentiated to hepatic cells on HepaRG ACM.
∑ Matrigel overlay improved hepatic maturation.
∑ We report the importance of the matrix in hepatic differentiation.
